References
- Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991;88:8495–9.
- Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996;24:714–7.
- Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol 2001;34:584–6.
- Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, . YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay. J Gastroenterol Hepatol 2006;21:1783–8.
- Zhao JR, Bai YJ, Zhang QH, Wan Y, Li D, Yan XJ. Detection of hepatitis B virus DNA by real-time PCR using TaqMan-MGB probe technology. World J Gastroenterol 2005;11:508–10.
- Zhao JR, Bai YJ, Wang Y, Zhang QH, Luo M, Yan XJ. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9: 328–32.
- Zhao JR, Bai YJ, Zhang QH, Wang Y, Luo M, Yan XJ. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2005;51:135–7.
- Yoshida S, Hige S, Yoshida M, Yamashita N, Fujisawa S, Sato K, . Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B. Ann Clin Biochem 2008;45:59–64.
- Lok AS, Zoulim F, Locarnini S, Mangia A, Niro G, Decraemer H, . Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J Clin Microbiol 2002;40:3729–34.
- Chen LY, Huang J, Zhang XP, Qiao P, Zhang W, Yang NM, . Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance. Pharmacogenomics 2005;6:721–30.
- Malmström S, Hannoun C, Lindh M. Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR. J Virol Methods 2007;143:147–52.
- Lindström A, Odeberg J, Albert J. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J Clin Microbiol 2004;42:4788–95.
- Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, Capobianchi MR. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol 2009;83:1718–26.
- Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, . Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 2009;199: 1275–85.